Business Standard

Moderna to charge govts $25-$37 for Covid-19 vaccine: CEO tells paper

Moderna has said its experimental vaccine is 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

In this July 27, 2020, file photo, a nurse prepares a shot that is part of a possible Covid-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. (AP Photo/Hans Pennink, File)

Reuters Frankfurt
Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly 'Welt am Sonntag' (WamS).

"Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50," he was quoted as saying.

On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below $25 per dose.

"Nothing is signed yet, but we're close to a

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 22 2020 | 5:37 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com